StockDuty ← Dashboard Oct 22, 2026 07:25 PM ET
CatalystFDA/Bio

Moderna has a plan to revolutionize how certain cancers are treated. We’re about to find out its potential in melanoma.

Moderna's cancer vaccine trial results carry high stakes for the company.

What happened: Moderna is set to reveal full Phase 3 trial data for its custom cancer treatment this weekend. Why it matters: Moderna is one of the hottest stocks of the year because of this treatment, so a lot is riding on the data. Key numbers: Full Phase 3 data are due this weekend.
Moderna is set to reveal full Phase 3 trial data for its custom cancer treatment this weekend.
Moderna is one of the hottest stocks of the year because of this treatment, so a lot is riding on the data. Key numbers: Full Phase 3 data are due this weekend.
Sources